These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 10722581)

  • 1. Immunity to onchocerciasis: cells from putatively immune individuals produce enhanced levels of interleukin-5, gamma interferon, and granulocyte-macrophage colony-stimulating factor in response to Onchocerca volvulus larval and male worm antigens.
    Turaga PS; Tierney TJ; Bennett KE; McCarthy MC; Simonek SC; Enyong PA; Moukatte DW; Lustigman S
    Infect Immun; 2000 Apr; 68(4):1905-11. PubMed ID: 10722581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential cytokine and antibody responses to adult and larval stages of Onchocerca volvulus consistent with the development of concomitant immunity.
    MacDonald AJ; Turaga PS; Harmon-Brown C; Tierney TJ; Bennett KE; McCarthy MC; Simonek SC; Enyong PA; Moukatte DW; Lustigman S
    Infect Immun; 2002 Jun; 70(6):2796-804. PubMed ID: 12010965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory effects of Th1-type (IFN-gamma, IL-12) and Th2-type cytokines (IL-10, IL-13) on parasite-specific cellular responsiveness in Onchocerca volvulus-infected humans and exposed endemic controls.
    Soboslay PT; Lüder CG; Riesch S; Geiger SM; Banla M; Batchassi E; Stadler A; Schulz-Key H
    Immunology; 1999 Jun; 97(2):219-25. PubMed ID: 10447735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoregulation in onchocerciasis: predominance of Th1-type responsiveness to low molecular weight antigens of Onchocerca volvulus in exposed individuals without microfilaridermia and clinical disease.
    Lüder CG; Schulz-Key H; Banla M; Pritze S; Soboslay PT
    Clin Exp Immunol; 1996 Aug; 105(2):245-53. PubMed ID: 8706329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Onchocerca volvulus cysteine proteinase inhibitor, Ov-CPI-2, is a target of protective antibody response that increases with age.
    Cho-Ngwa F; Liu J; Lustigman S
    PLoS Negl Trop Dis; 2010 Aug; 4(8):e800. PubMed ID: 20808763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ivermectin-facilitated immunity in onchocerciasis; activation of parasite-specific Th1-type responses with subclinical Onchocerca volvulus infection.
    Soboslay PT; Lüder CG; Hoffmann WH; Michaelis I; Helling G; Heuschkel C; Dreweck CM; Blanke CH; Pritze S; Banla M
    Clin Exp Immunol; 1994 May; 96(2):238-44. PubMed ID: 8187332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ov-ASP-1, the Onchocerca volvulus homologue of the activation associated secreted protein family is immunostimulatory and can induce protective anti-larval immunity.
    MacDonald AJ; Tawe W; Leon O; Cao L; Liu J; Oksov Y; Abraham D; Lustigman S
    Parasite Immunol; 2004 Jan; 26(1):53-62. PubMed ID: 15198646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection.
    Soboslay PT; Geiger SM; Weiss N; Banla M; Lüder CG; Dreweck CM; Batchassi E; Boatin BA; Stadler A; Schulz-Key H
    Immunology; 1997 Apr; 90(4):592-9. PubMed ID: 9176114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory effects of IL-12 and IL-18 on Onchocerca volvulus- and Entamoeba histolytica-specific cellular reactivity and cytokine profiles.
    Pfaff AW; Kirch AK; Hoffmann WH; Banla M; Schulz-Key H; Geiger SM; Soboslay PT
    Parasite Immunol; 2003 Jun; 25(6):325-32. PubMed ID: 14507330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in cytokine responses to Onchocerca volvulus extract and recombinant Ov33 and OvL3-1 proteins in exposed subjects with various parasitologic and clinical states.
    Brattig N; Nietz C; Hounkpatin S; Lucius R; Seeber F; Pichlmeier U; Pogonka T
    J Infect Dis; 1997 Sep; 176(3):838-42. PubMed ID: 9291349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of both IFN-gamma and IL-5 by Onchocerca volvulus S1 antigen-specific CD4+ T cells from putatively immune individuals.
    Doetze A; Erttmann KD; Gallin MY; Fleischer B; Hoerauf A
    Int Immunol; 1997 May; 9(5):721-9. PubMed ID: 9184917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal immune priming in onchocerciasis-onchocerca volvulus-specific cellular responsiveness and cytokine production in newborns from infected mothers.
    Soboslay PT; Geiger SM; Drabner B; Banla M; Batchassi E; Kowu LA; Stadler A; Schulz-Key H
    Clin Exp Immunol; 1999 Jul; 117(1):130-7. PubMed ID: 10403926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental onchocerciasis in chimpanzees: cellular responses and antigen recognition after immunization and challenge with Onchocerca volvulus infective third-stage larvae.
    Lüder CG; Soboslay PT; Prince AM; Greene BM; Lucius R; Schulz-Key H
    Parasitology; 1993 Jul; 107 ( Pt 1)():87-97. PubMed ID: 8356001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Onchocerca volvulus-exposed persons fail to produce interferon-gamma in response to O. volvulus antigen but mount proliferative responses with interleukin-5 and IL-13 production that decrease with increasing microfilarial density.
    Brattig NW; Lepping B; Timmann C; Büttner DW; Marfo Y; Hamelmann C; Horstmann RD
    J Infect Dis; 2002 Apr; 185(8):1148-54. PubMed ID: 11930325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunity to onchocerciasis: putative immune persons produce a Th1-like response to Onchocerca volvulus.
    Elson LH; Calvopiña M; Paredes W; Araujo E; Bradley JE; Guderian RH; Nutman TB
    J Infect Dis; 1995 Mar; 171(3):652-8. PubMed ID: 7876612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+-dependent immunity to Onchocerca volvulus third-stage larvae in humans and the mouse vaccination model: common ground and distinctions.
    Lustigman S; MacDonald AJ; Abraham D
    Int J Parasitol; 2003 Sep; 33(11):1161-71. PubMed ID: 13678632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental onchocerciasis in chimpanzees. Antibody response and antigen recognition after primary infection with Onchocerca volvulus.
    Soboslay PT; Weiss N; Dreweck CM; Taylor HR; Brotman B; Schulz-Key H; Greene BM
    Exp Parasitol; 1992 Jun; 74(4):367-80. PubMed ID: 1592090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient changes in cytokine profiles following ivermectin treatment of onchocerciasis.
    Steel C; Lujan-Trangay A; Gonzalez-Peralta C; Zea-Flores G; Nutman TB
    J Infect Dis; 1994 Oct; 170(4):962-70. PubMed ID: 7930742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective immunity against Onchocerca volvulus and O. lienalis infective larvae in mice.
    Taylor MJ; van Es RP; Shay K; Folkard SG; Townson S; Bianco AE
    Trop Med Parasitol; 1994 Mar; 45(1):17-23. PubMed ID: 8066376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody responses against the vaccine antigens Ov-103 and Ov-RAL-2 are associated with protective immunity to Onchocerca volvulus infection in both mice and humans.
    George PJ; Hess JA; Jain S; Patton JB; Zhan T; Tricoche N; Zhan B; Bottazzi ME; Hotez PJ; Abraham D; Lustigman S
    PLoS Negl Trop Dis; 2019 Sep; 13(9):e0007730. PubMed ID: 31525197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.